Global Community

STEELCASE FAIR VALUE ANALYSIS Target Price: $15.60 Valuation Methodology Based on sector-relative P/E analysis , Steelcase appears moderately undervalued. Using TTM EPS of $1.04 and applying the furniture industry average P/E multiple of 15x, the intrinsic fair value equals $15.60 per share.

Red Star Express Plc projects a net cash inflow of ₦145.67 million for the second quarter of 2025 (July–September), signaling strong operational cash generation capacity even amid ongoing capital expenditure and debt servicing. The company expects to end the quarter with ₦726.71 million in cash and cash equivalents , up from ₦581.04 million at the start of the period.

Disclaimer: As a private investor, I share this personal analysis of Titan Cement for educational purposes. This is NOT investment advice This analysis is provided for informational and educational purposes only.

1. Platform Model: Mobility, Delivery & Logistics Uber operates a global two-sided marketplace , connecting riders, couriers, and freight shippers with independent drivers without owning vehicles or inventory.

Pipeline Crenessity@ CRENESSITY Capsule 50/100 MG $766.66 packaging 50 MG 60u $45,999.60 packaging 100 MG 30u. Starts at approximately $21,338.71 USD for a monthly supply Ingrezza@ Ingrezza (valbenazine) As of July 2025 , the average pharmacy acquisition cost for Ingrezza capsules in the U.S. is approximately: $274.54 per capsule for the 60 mg and 80 mg strengths $250.16 per capsule for the 40 mg strength Other Products: Tetrabenazine Tablet 12.5 MG $62.52 Austedo Tablet 6 MG $100.06 Austedo XR Tablet 6 MG $100.06 Xenazine Tablet 12.5 MG $227.88 Assumptions Risks Risks and uncertainties associated with Neurocrine Biosciences' business and finances in general, risks and uncertainties associated with the commercialization of INGREZZA and CRENESSITY.

To estimate the potential stock price of 1911 Gold Corp if gold reaches $4,000 per oz, we can consider the following: Current Resource Base : The company has a significant resource base, including: True North Mine: 1 million oz at 6 gpt. Ogama-Rockland: 300,000 oz at 8 gpt.

Shorts are manipulating the stock. The fundamentals are too strong to ignore.

Today, July 29 Novo revised its full year 2025 guidance downward: Sales growht in local currencies now expected 8% - 14%. (down from 13% -21%.) Operating profit growth: now expected 10% -16%, ( down from 16% x24%).

competitor to adobe. (media production software--very active sector) new issue (IPO) subscription buyers at $32.